Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07043101 · ClinicalTrials.gov registry record · NA
Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation
A NA study of Gait Rehabilitation, sponsored by University at Albany.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07043101: Recruiting NA study of Gait Rehabilitation, sponsored by University at Albany.
NCT07043101 is a NA study of Gait Rehabilitation that is actively recruiting participants, run by University at Albany. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07043101, a NA study of Gait Rehabilitation, is actively recruiting participants, sponsored by University at Albany.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will evaluate the feasibility and preliminary effectiveness of incorporating Extended Reality (XR) into the treatment of patients undergoing Lower Limb Rehabilitation (LLR) using the Vector Gait and Safety System. LLR requires repetitive motions over the span of weeks or months with the aim of restoring mobility. This duration of time poses challenges with motivation and increases the burden on the physical therapists. The use of XR in conjunction with conventional physical therapy could significantly increase motivation, along with providing therapists with new ways of tracking the patient's recovery. Pilot study results will be used to propose new and innovative approaches to physical recovery during inpatient rehabilitation, potentially increasing motivation, enhancing therapy participation, and reducing the overall time taken for recovery.
Primary Outcome
Establish the efficacy of integrating Extended Reality (XR) with Vector treatment sessions during inpatient rehabilitation by monitoring the change in gait speed over sessions.
Conditions Studied
Interventions
- OTHER Extended Reality based Gait Rehabilitation
Study Locations (1)
New York
- Sunnyview Rehabilitation Hospital - Schenectady
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2025-08-15 |
| Phase | NA |
What NCT07043101 shows while recruiting
NCT07043101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Gait Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Extended Reality based Gait Rehabilitation is the first listed.
NCT07043101 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07043101 about?
NCT07043101 is a clinical study titled "Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation". This pilot study will evaluate the feasibility and preliminary effectiveness of incorporating Extended Reality (XR) into the treatment of patients undergoing Lower Limb Rehabilitation (LLR) using the Vector Gait and Safety System. LLR requires repetitive motions over the span of weeks or months with...
What is the current status of trial NCT07043101?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-05-12. Estimated completion is 2025-08-15.
What conditions does trial NCT07043101 study?
This clinical trial studies the following conditions: Gait Rehabilitation.
What interventions are being tested in trial NCT07043101?
The interventions under investigation include: Extended Reality based Gait Rehabilitation (OTHER).
Who is sponsoring clinical trial NCT07043101?
This trial is sponsored by University at Albany, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07043101 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07043101's enrollment target sits among peer trials
24 1737th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI